Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.1, 2006-01, pp. : 25-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation préclinique de la sécurité des produits issus des biotechnologies : aspects spécifiques: Preclinical Safety Evaluation of Biotechnology-Derived Products: Specific Aspects

By Descotes Jacques Ravel Guillaume Vial Thierry

Therapie, Vol. 58, Iss. 2, 2003-01 ,pp. : 139-143

Adis International

Access to resources Recommend Favorite

Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-12 ,pp. : 60-68

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases: Progress in Development

By Rowe Steven M. Clancy John P.

BioDrugs, Vol. 23, Iss. 3, 2009-06 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

Applying self-determination theory for improved understanding of physiotherapists’ rationale for using research in clinical practice: a qualitative study in Sweden

By Dannapfel Petra Peolsson Anneli Ståhl Christian Öberg Birgitta Nilsen Per

Physiotherapy Theory and Practice, Vol. 30, Iss. 1, 2014-01 ,pp. : 20-28

Informa Healthcare

Access to resources Recommend Favorite

Inspiration and Guidance

By Keeling Arlene

Nursing History Review, Vol. 22, Iss. 1, 2014-01 ,pp. : 126-131

Springer Publishing Company

Access to resources Recommend Favorite